The patent relates to the use of compositions for the prevention and/or treatment of pathologies related to alpha-glucosidase and especially to the use of compositions for the prevention and/or treatment of type 2 diabetes.
Brief outline of the case
The OD admitted in the procedure the late filed ground of opposition under Art 100(b).